NEUTRALISING ANTIBODIES TO INTERFERON-BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS

被引：0
|
作者：
Gafson, Arie
Worthington, Viki
Lakdawala, Neghat
Giovannoni, Gavin
Farrell, Rachel
机构：
[1] UCL, Inst Neurol, London WC1E 6BT, England
[2] Barts & London Queen Marys Sch Med & Dent, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2013年 / 84卷 / 11期
关键词：
D O I：
10.1136/jnnp-2013-306573.176
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neutralising antibodies to interferon β during the treatment of multiple sclerosis
    Polman, CH
    Kappos, L
    Petkau, J
    Thompson, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (08): : 1162 - 1162
  • [32] A weighted genetic risk score to predict neutralising antibodies to interferon-β in multiple sclerosis patients
    Hemmer, B.
    Igl, W.
    Buck, D.
    Muehlau, M.
    Schwenke, S.
    Mueller-Myhsok, B.
    Sandbrink, R.
    Pohl, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 361 - 361
  • [33] Immune tolerance induction with high-dose intravenous interferon-beta in multiple sclerosis patients with neutralising antibodies - a pilot study
    Hegen, H.
    Guger, M.
    Harrer, A.
    Hoelzl, M.
    Kraus, J.
    Schautzer, F.
    Schmidegg, S.
    Skrobal, A.
    Deisenhammer, F.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S424 - S425
  • [34] Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
    Hegen, H.
    Millonig, A.
    Bertolotto, A.
    Comabella, M.
    Giovanonni, G.
    Guger, M.
    Hoelzl, M.
    Khalil, M.
    Killestein, J.
    Lindberg, R.
    Malucchi, S.
    Mehling, M.
    Montalban, X.
    Polman, C. H.
    Rudzki, D.
    Schautzer, F.
    Sellebjerg, F.
    Sorensen, P. S.
    Deisenhammer, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (05) : 577 - 587
  • [35] Interferon beta 1a for secondary progressive multiple sclerosis
    Hughes, RAC
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) : 199 - 202
  • [36] Suggested limits for high and low neutralising antibody levels in interferon-beta treated multiple sclerosis patients
    Gibbs, E.
    Oger, J.
    MULTIPLE SCLEROSIS, 2006, 12 : S204 - S204
  • [37] Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients
    Kalluri, Sudhakar Reddy
    Grummel, Verena
    Hracsko, Zsuzsanna
    Pongratz, Viola
    Pernpeintner, Verena
    Gasperi, Christiane
    Buck, Dorothea
    Hemmer, Bernhard
    JOURNAL OF AUTOIMMUNITY, 2018, 88 : 83 - 90
  • [38] Interferon-beta signal transduction, multiple sclerosis and auto-antibodies
    Gavasso, Sonia
    Skavland, Jorn
    Gjertsen, Bjorn Tore
    Myhr, Kjell-Morten
    Vedeler, Christian
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 134 - 135
  • [39] Mechanisms of action of interferon-beta in multiple sclerosis
    Arnason, BGW
    Dayal, A
    Qu, ZX
    Jensen, MA
    Genc, K
    Reder, AT
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1996, 18 (01): : 125 - 148
  • [40] INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS
    METZ, L
    BELL, R
    ZOCHODNE, O
    NEUROLOGY, 1994, 44 (01) : 187 - 188
12345